Skip to main content
SpringerLink
Log in

Hemorrhagic Cystitis

  • Chapter
  • First Online:
Urological Emergencies

Part of the book series: Current Clinical Urology ((CCU))

  • 1491 Accesses

Abstract

Hemorrhagic cystitis is a common and potentially devastating urological disorder. Among the risk factors associated with the disease, previous pelvic irradiation and chemotherapeutic drugs such as cyclophosphamide are the most common etiologies of HC. Clinically, HC presents as hematuria often with progression to clot retention. Histologically, chronic fibrosis and progressive endarteritis are seen. Treatment for HC varies with the degree of hematuria. Treatment may include: urinary drainage, intravesical irrigation with topical astringents, and direct fulguration. Ultimately, the most durable and effective therapy for HC may be systemic hyperbaric oxygen therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Cheng C, Foo KT. Management of severe chronic radiation cystitis. Ann Acad Med Singapore. 1992; 21(3):368–71.

    PubMed  CAS  Google Scholar 

  2. Wong TM, Yeo W, Chan LW, Mok TS. Hemorrhagic pyelitis, ureteritis and cystitis secondary to cyclophosphamide: case report and review of literature. Gynecol Oncol. 2000;76(2):223–5.

    Article  PubMed  CAS  Google Scholar 

  3. Levenback C, Eifel PJ, Burke TW, Morris M, Gershenson DM. Hemorrhagic cystitis following radiotherapy for stage Ib cancer of the cervix. Gynecol Oncol. 1994;55(2):206–10.

    Article  PubMed  CAS  Google Scholar 

  4. Sell A, Bertelsen K, Andersen JE, Stroyer I, Panduro J. Randomized study of whole-abdomen irradiation vs pelvic irradiation plus cyclophosphamide in treatment of early ovarian cancer. Gynecol Oncol. 1990; 37(3):367–73.

    Article  PubMed  CAS  Google Scholar 

  5. de Vries CR, Freiha FS. Hemorrhagic cystitis: a review. J Urol. 1990;143(1):1–9.

    Article  Google Scholar 

  6. Rieger KE, Hong WJ, Tusher VJ, et al. Toxicity from radiation therapy associated with abnormal transcriptional responses to DNA damage. Proc Natl Acad Sci U S A. 2004;101(17):6635–40.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  7. Sencer SF, Haake RJ, Weisdorf DJ. Hemorrhagic cystitis after bone marrow transplantation. Risk factors and complications. Transplantation. 1993;56(4):875–9.

    Article  PubMed  CAS  Google Scholar 

  8. Stillwell TJ, Benson Jr RC. Cyclophosphamide-induced hemorrhagic cystitis. A review of 100 patients. Cancer. 1988;61(3):451–7.

    Article  PubMed  CAS  Google Scholar 

  9. Brugieres L, Hartmann O, Travagli JP, et al. Hemorrhagic cystitis following high-dose chemotherapy and bone marrow transplantation in children with malignancies: incidence, clinical course, and outcome. J Clin Oncol. 1989;7(2):194–9.

    PubMed  CAS  Google Scholar 

  10. Mahjoubi M, Azab M, Ghosn M, Theodore C, Droz JP. Phase II trial of ifosfamide in the treatment of metastatic hormone-refractory patients with prostatic cancer. Cancer Invest. 1990;8(5):477–81.

    Article  PubMed  CAS  Google Scholar 

  11. Sarosy G. Ifosfamide—pharmacologic overview. Semin Oncol. 1989;16(1 Suppl 3):2–8.

    PubMed  CAS  Google Scholar 

  12. Shanholtz C. Acute life-threatening toxicity of cancer treatment. Crit Care Clin. 2001;17(3):483–502.

    Article  PubMed  CAS  Google Scholar 

  13. Pihusch R, Salat C, Schmidt E, et al. Hemostatic complications in bone marrow transplantation: a retrospective analysis of 447 patients. Transplantation. 2002;74(9):1303–9.

    Article  PubMed  Google Scholar 

  14. Hong WK, Nicaise C, Lawson R, et al. Etoposide combined with cyclophosphamide plus vincristine compared with doxorubicin plus cyclophosphamide plus vincristine and with high-dose cyclophosphamide plus vincristine in the treatment of small-cell carcinoma of the lung: a randomized trial of the Bristol Lung Cancer Study Group. J Clin Oncol. 1989;7(4):450–6.

    PubMed  CAS  Google Scholar 

  15. Stillwell TJ, Benson Jr RC, DeRemee RA, McDonald TJ, Weiland LH. Cyclophosphamide-induced bladder toxicity in Wegener’s granulomatosis. Arthritis Rheum. 1988;31(4):465–70.

    Article  PubMed  CAS  Google Scholar 

  16. Hu RQ, Mehter H, Nadasdy T, et al. Severe hemorrhagic cystitis associated with prolonged oral cyclophosphamide therapy: case report and literature review. Rheumatol Int. 2008;28:1161–4.

    Article  PubMed  Google Scholar 

  17. Stillwell TJ, Benson Jr RC, Burgert Jr EO. Cyclophosphamide-induced hemorrhagic cystitis in Ewing’s sarcoma. J Clin Oncol. 1988;6(1):76–82.

    PubMed  CAS  Google Scholar 

  18. Williams SF, Bitran JD, Hoffman PC, et al. High-dose, multi-alkylator chemotherapy with autologous bone marrow reinfusion in patients with advanced non-small cell lung cancer. Cancer. 1989;63(2):238–42.

    Article  PubMed  CAS  Google Scholar 

  19. Heyn R, Raney Jr RB, Hays DM, Tefft M, Gehan E, Webber B, et al. Late effects of therapy in patients with paratesticular rhabdomyosarcoma. Intergroup Rhabdomyosarcoma Study Committee. J Clin Oncol. 1992;10(4):614–23.

    PubMed  CAS  Google Scholar 

  20. Allen JC. Complications of chemotherapy in patients with brain and spinal cord tumors. Pediatr Neurosurg. 1991;17(4):218–24.

    Article  PubMed  Google Scholar 

  21. Crilley P, Topolsky D, Bulova S, Bigler R, Brodsky I. Bone marrow transplantation following busulfan and cyclophosphamide for acute myelogenous leukemia. Bone Marrow Transplant. 1990;5(3):187–91.

    PubMed  CAS  Google Scholar 

  22. Islam R, Isaacson BJ, Zickerman PM, Ratanawong C, Tipping SJ. Hemorrhagic cystitis as an unexpected adverse reaction to temozolomide: case report. Am J Clin Oncol. 2002;25(5):513–4.

    Article  PubMed  Google Scholar 

  23. Mylonakis E, Goes N, Rubin RH, Cosimi AB, Colvin RB, Fishman JA. BK virus in solid organ transplant recipients: an emerging syndrome. Transplantation. 2001;72(10):1587–92.

    Article  PubMed  CAS  Google Scholar 

  24. Reploeg MD, Storch GA, Clifford DB. BK virus: a clinical review. Clin Infect Dis. 2001;33(2):191–202.

    Article  PubMed  CAS  Google Scholar 

  25. Iwamoto S, Azuma E, Hori H, et al. BK virus-associated fatal renal failure following late-onset hemorrhagic cystitis in an unrelated bone marrow transplantation. Pediatr Hematol Oncol. 2002; 19(4):255–61.

    Article  PubMed  Google Scholar 

  26. Bielorai B, Shulman LM, Rechavi G, Toren A. CMV reactivation induced BK virus-associated late onset hemorrhagic cystitis after peripheral blood stem cell transplantation. Bone Marrow Transplant. 2001; 28(6):613–4.

    Article  PubMed  CAS  Google Scholar 

  27. Akiyama H, Kurosu T, Sakashita C, et al. Adenovirus is a key pathogen in hemorrhagic cystitis associated with bone marrow transplantation. Clin Infect Dis. 2001;32(9):1325–30.

    Article  PubMed  CAS  Google Scholar 

  28. Echavarria MS, Ray SC, Ambinder R, Dumler JS, Charache P. PCR detection of adenovirus in a bone marrow transplant recipient: hemorrhagic cystitis as a presenting manifestation of disseminated disease. J Clin Microbiol. 1999;37(3):686–9.

    PubMed  CAS  PubMed Central  Google Scholar 

  29. Boubenider S, Hiesse C, Marchand S, Hafi A, Kriaa F, Charpentier B. Post-transplantation polyomavirus infections. J Nephrol. 1999;12(1):24–9.

    PubMed  CAS  Google Scholar 

  30. Leung AY, Suen CK, Lie AK, Liang RH, Yuen KY, Kwong YL. Quantification of polyoma BK viruria in hemorrhagic cystitis complicating bone marrow transplantation. Blood. 2001;98(6):1971–8.

    Article  PubMed  CAS  Google Scholar 

  31. Azzi A, Fanci R, Bosi A, et al. Monitoring of polyomavirus BK viruria in bone marrow transplantation patients by DNA hybridization assay and by polymerase chain reaction: an approach to assess the relationship between BK viruria and hemorrhagic cystitis. Bone Marrow Transplant. 1994;14(2):235–40.

    PubMed  CAS  Google Scholar 

  32. Londergan TA, Walzak MP. Hemorrhagic cystitis due to adenovirus infection following bone marrow transplantation. J Urol. 1994;151(4):1013–4.

    PubMed  CAS  Google Scholar 

  33. Bil-Lula I, Ussowicz M, Rybka B, et al. Hematuria due to adenoviral infection in bone marrow transplant patients. Transplant Proc. 2010;42:3729–34.

    Article  PubMed  CAS  Google Scholar 

  34. Barouch DH, Faquin WC, Chen Y, Koralnik IK, Robbins GK, Davis BT. BK virus-associated hemorrhagic cystitis in a human immunodeficiency virus-infected patient. Clin Infect Dis. 2002;35(3):326–9.

    Article  PubMed  Google Scholar 

  35. Toma Y, Ishiki T, Nagahama K, et al. Penicillin-G induced hemorrhagic cystitis with hydronephrosis. Intern Med. 2009;48:1667–9.

    Article  PubMed  Google Scholar 

  36. Lopez AE, Rodriguez S, Flores I. Management of ischemic hemorrhagic cystitis with hyperbaric oxygen therapy. Undersea Hyperb Med. 2001; 28(1):35–6.

    PubMed  CAS  Google Scholar 

  37. Koh LP. Boon’s disease: hemorrhagic cystitis in conjunction with massive exfoliation of degenerated urothelial cells (apoptosis?) during intercontinental flights in an otherwise healthy person. Diagn Cytopathol. 2001;25(6):361–4.

    Article  Google Scholar 

  38. Messing EM, Catalona W. Urothelial tumors of the urinary tract. In: Walsh PC, Retik AB, Vaughan Jr ED, Wein AJ, editors. Campbell’s urology, vol. 3. 7th ed. Philadelphia: Saunders; 1998. p. 2327–410.

    Google Scholar 

  39. Pedersen-Bjergaard J, Ersboll J, Hansen VL, et al. Carcinoma of the urinary bladder after treatment with cyclophosphamide for non-Hodgkin’s lymphoma. N Engl J Med. 1988;318(16):1028–32.

    Article  PubMed  CAS  Google Scholar 

  40. Kondo M, Kojima S, Kato K, Matsuyama T. Late-onset hemorrhagic cystitis after hemotopoietic stem cell transplantation in children. Bone Marrow Transplant. 1998;22(10):995–8.

    Article  PubMed  CAS  Google Scholar 

  41. Nevo S, Swan V, Enger C, et al. Acute bleeding after bone marrow transplantation (BMT)—incidence and effect on survival. A quantitative analysis in 1402 patients. Blood. 1998;91(4):1469–77.

    PubMed  CAS  Google Scholar 

  42. Avidor Y, Nadu A, Matzkin H. Clinical significance of gross hematuria and its evaluation in patients receiving anticoagulant and aspirin treatment. Urology. 2000;55(1):22–4.

    Article  PubMed  CAS  Google Scholar 

  43. Worawattanakul S, Semelka RC, Kelekis NL. Post radiation hemorrhagic cystitis: MR findings. Magn Reson Imaging. 1997;15(9):1103–6.

    Article  PubMed  CAS  Google Scholar 

  44. Cartoni C, Arcese W, Avvisati G, Corinto L, Capua A, Meloni G. Role of ultrasonography in the diagnosis and follow-up of hemorrhagic cystitis after bone ­marrow transplantation. Bone Marrow Transplant. 1993;12(5):463–7.

    PubMed  CAS  Google Scholar 

  45. Katz A, Epelman S, Anelli A, et al. A prospective randomized evaluation of three schedules of mesna administration in patients receiving an ifosfamide-containing chemotherapy regime: sustained efficiency and simplified administration. J Cancer Res Clin Oncol. 1995;121(2):128–31.

    Article  PubMed  CAS  Google Scholar 

  46. Meisenberg B, Lassiter M, Hussein A, Ross M, Vredenburgh JJ, Peters WP. Prevention of hemorrhagic cystitis after high-dose alkylating agent chemotherapy and autologous bone marrow support. Bone Marrow Transplant. 1994;14(2):287–91.

    PubMed  CAS  Google Scholar 

  47. Luce JK, Simons JA. Efficacy of mesna in preventing further cyclophosphamide-induced hemorrhagic cystitis. Med Pediatr Oncol. 1988;16(6):372–4.

    Article  PubMed  CAS  Google Scholar 

  48. Haselberger MB, Schwinghammer TL. Efficacy of mesna for prevention of hemorrhagic cystitis after high-dose cyclophosphamide therapy. Ann Pharmacother. 1995;29(9):918–21.

    PubMed  CAS  Google Scholar 

  49. Reinhold-Keller E, Mohr J, Christophers E, Nordmann K, Gross WL. Mesna side effects which imitate vasculitis. Clin Investig. 1992;70(8):698–704.

    PubMed  CAS  Google Scholar 

  50. Vose JM, Reed EC, Pippert GC, et al. Mesna compared with continuous bladder irrigation as uroprotection during high-dose chemotherapy and transplantation: a randomized trial. J Clin Oncol. 1993;11(7):1306–10.

    PubMed  CAS  Google Scholar 

  51. Shepherd JD, Pringle LE, Barnett MJ, Klingemann HG, Reece DE, Phillips GL. Mesna vs hyperhydration for the prevention of cyclophosphamide-induced hemorrhagic cystitis in bone marrow transplantation. J Clin Oncol. 1991;9(11):2016–20.

    PubMed  CAS  Google Scholar 

  52. Ballen KK, Becker P, Levebvre K, et al. Safety and cost of hyperhydration for the prevention of hemorrhagic cystitis in bone marrow transplant recipients. Oncology. 1999;57(4):287–92.

    Article  PubMed  CAS  Google Scholar 

  53. Moon RE, Camporesi EM. Hyperbaric oxygen therapy: from the 19th to the 21st century. Respir Care Clin N Am. 1999;5(1):1–5.

    PubMed  CAS  Google Scholar 

  54. Hampson NB, editor. Hyperbaric oxygen therapy: 1999 Committee report. Kensington, MD: Undersea and Hyperbaric Medical Society; 1999.

    Google Scholar 

  55. Robertson PW, Hart BB. Assessment of tissue oxygenation. Respir Care Clin N Am. 1999;5(2):221–63.

    PubMed  CAS  Google Scholar 

  56. Marx RE, Ehler WJ, Tayapongsak P, et al. Relationship of oxygen dose to angiogenesis induction in irradiated tissue. Am J Surg. 1990;160(5):519–24.

    Article  PubMed  CAS  Google Scholar 

  57. Shoshani O, Shupak A, Ullmann Y, et al. The effect of hyperbaric oxygenation on the viability of human fat injected into nude mice. Plast Reconstr Surg. 2000; 106(6):1390–6.

    Article  PubMed  CAS  Google Scholar 

  58. Thorn JJ, Kallehave F, Westergaard P, et al. The effect of hyperbaric oxygen on irradiated oral tissues: transmucosal oxygen tension measurements. J Oral Maxillofac Surg. 1997;55(10):1103–7.

    Article  PubMed  CAS  Google Scholar 

  59. Matthew R, Rajan N, Josefson L, et al. Hyperbaric oxygen therapy for radiation induced hemorrhagic cystitis. J Urol. 1999;161(2):435–7.

    Article  Google Scholar 

  60. Bevers RF, Bakker DJ, Kurth KH. Hyperbaric oxygen treatment for hemorrhagic radiation cystitis. Lancet. 1995;346(8978):803–5.

    Article  PubMed  CAS  Google Scholar 

  61. Norkool DM, Hampson NB, Gibbons RP, et al. Hyperbaric oxygen therapy for radiation-induced hemorrhagic cystitis. J Urol. 1993;150(2 Pt 1):332–4.

    PubMed  CAS  Google Scholar 

  62. Weiss JP, Mattei DM, Neville EC, et al. Primary treatment of radiation-induced cystitis with hyperbaric oxygen: 10-year experience. J Urol. 1994; 151(6):1514–7.

    PubMed  CAS  Google Scholar 

  63. Crew JP, Jephcott CR, Reynard JM. Radiation-induced hemorrhagic cystitis. Eur Urol. 2002;40(2):111–23.

    Article  Google Scholar 

  64. Ennis RD. Hyperbaric oxygen for the treatment of radiation cystitis and proctitis. Curr Urol Rep. 2000;3(3):229–31.

    Article  Google Scholar 

  65. O’Reilly KJ, Hampson NB, Corman JM. Hyperbaric oxygen in urology, AUA update series lesson 4, vol. 21. Houston: American Urological Association; 2002. p. 26–31.

    Google Scholar 

  66. Feldmeier JJ, Hampson NB. A systematic review of the literature reporting the application of hyperbaric oxygen prevention and treatment of delayed radiation injuries: an evidence based approach. Undersea Hyperb Med. 2002;29(1):4–30.

    PubMed  CAS  Google Scholar 

  67. Corman JM, McClure RD, Pritchett TR, Kozlowski P, Hampson NB. Treatment of radiation-induced hemorrhagic cystitis with hyperbaric oxygen. J Urol. 2003;169:2200–2.

    Article  PubMed  Google Scholar 

  68. Al-Ali BM, Trummer H, Shamloul R, et al. Is treatment of hemorrhagic radiation cystitis with hyperbaric oxygen effective? Urol Int. 2010;84:467–70.

    Article  Google Scholar 

  69. Yoshida T, Kawashima A, Ujike T, et al. Hyperbaric oxygen therapy for radiation-induced hemorrhagic cystitis. Int J Urol. 2008;15:639–41.

    Article  PubMed  Google Scholar 

  70. Jou YC, Lien FC, Cheng MC, et al. Hyperbaric oxygen therapy for cyclophosphamide-induced intractable refractory hemorrhagic cystitis in a systemic lupus erythematous patient. J Chin Med Assoc. 2008; 71:218–20.

    Article  PubMed  Google Scholar 

  71. Gol AK, Rao MS, Bhagwat AG, et al. Intravesical irrigation with alum for the control of massive bladder hemorrhage. J Urol. 1985;133:956–7.

    Google Scholar 

  72. Gattegno B, Guillemenot F, Fiatte P, et al. Treatment of HC caused by cyclophosphamide using intravesical installation of potassium alum: a propos of 5 cases. Ann Urol. 1990;24:190–2.

    CAS  Google Scholar 

  73. Bogris S, Johal NS, Musgtaq I. Commentary to “pediatric hemorrhagic cystitis”. J Pediatr Urol. 2010;6:98.

    Article  PubMed  Google Scholar 

  74. Kanwar VS, Jenkins JJ, Mandrell BN. Aluminium toxicity following intravesical alum irrigation for hemorrhagic cystitis. Med Pediatr Oncol. 1996; 27(1):64–7.

    Article  PubMed  CAS  Google Scholar 

  75. Sarnak MJ, Long J, King AJ. Intravesicular formaldehyde instillation and renal complications. Clin Nephrol. 1999;51(2):122–5.

    PubMed  CAS  Google Scholar 

  76. Stefanini M, English HA, Taylor AE. Safe and ­effective, prolonged administration of epsilon-aminocaproic acid in bleeding from the urinary tract. J Urol. 1990;143(3):559–61.

    PubMed  CAS  Google Scholar 

  77. Pitts TO, Spero JA, Bontempo FA, et al. Acute renal failure due to high grade obstruction following therapy with epsilon-aminocaproic acid. Am J Kidney Dis. 1986;8:441–4.

    PubMed  CAS  Google Scholar 

  78. Ippoliti C, Przepiorka D, Mehra R, et al. Intravesical carboprost for the treatment of hemorrhagic cystitis after marrow transplantation. Urology. 1995; 46(6):811–5.

    Article  PubMed  CAS  Google Scholar 

  79. Laszlo D, Bosi A, Guidi S, et al. Prostaglandin E2 bladder instillation for the treatment of hemorrhagic cystitis after allogenic bone marrow transplantation. Haematologica. 1995;80(5):421–5.

    PubMed  CAS  Google Scholar 

  80. Trigg ME, O’Reilly J, Rumelhart S, Morgan D, Holida M, de Alarcon P. Prostaglandin E1 bladder instillations to control severe hemorrhagic cystitis. J Urol. 1990;143(1):92–4.

    PubMed  CAS  Google Scholar 

  81. Raghavaiah NV, Soloway MS. Anuria following silver nitrate irrigation for intractable bladder hemorrhage. J Urol. 1977;118:681–2.

    PubMed  CAS  Google Scholar 

  82. Andrei G, Snoeck R, Vandeputte M, et al. Activities of various compounds against murine and primate polyomaviruses. Antimicrob Agents Chemother. 1997;41:587–93.

    PubMed  CAS  PubMed Central  Google Scholar 

  83. Bridges B, Donegan S, Badros A. Cidofovir instillation for the treatment of BK hemorrhagic cystitis after allogenic stem cell transplantation. Am J Hematol. 2006;81:535–7.

    Article  PubMed  Google Scholar 

  84. Mullholland SG, Hanno P, Parsons CL, et al. Pentosan polysulfate sodium for therapy of interstitial cystitis. Urology. 1990;35:552–8.

    Article  Google Scholar 

  85. Hampson SJ, Woodhouse CR. Sodium pentosan polysulfate in the management of hemorrhagic cystitis: experience with 14 patients. Eur Urol. 1994;25:40–2.

    PubMed  CAS  Google Scholar 

  86. Toren PJ, Norman RW. Cyclophosphamide-induced hemorrhagic cystitis successfully treated with pentosanpolysulfate. J Urol. 2005;173:103.

    Article  PubMed  Google Scholar 

  87. Ritch CR, Poon SA, Sulis ML, et al. Cutaneous vesicostomy for palliative management of hemorrhagic cystitis and urinary clot retention. J Urol. 2010;76:166–8.

    Article  Google Scholar 

  88. Lang EK. Transcatheter embolization of pelvic vessels for control of intractable hemorrhage. Radiology. 1981;140:331–9.

    PubMed  CAS  Google Scholar 

  89. Han Y, Wu D, Sun A, et al. Selective embolization of the internal iliac arteries for the treatment of severe hemorrhagic cystitis following hematopoietic SCT. Bone Marrow Transplant. 2008;41:881–6.

    Article  PubMed  CAS  Google Scholar 

  90. Koc S, Hagglund H, Ireton RC, Perez-Simon JA, Collins SJ, Appelbaum FR. Successful treatment of severe hemorrhagic cystitis with cystectomy following matched donor allogenic hematopoietic cell transplantation. Bone Marrow Transplant. 2000;26(8):899–901.

    Article  PubMed  CAS  Google Scholar 

  91. Miyamura K, Hamaguchi M, Taji H, et al. Successful ribavirin therapy for severe adenovirus hemorrhagic cystitis after allogenic marrow transplant from close HLA donors rather than distant donors. Bone Marrow Transplant. 2000;25(5):545–8.

    Article  PubMed  CAS  Google Scholar 

  92. Seabra C, Perez-Simon JA, Sierra M, et al. Intramuscular vidarabine therapy for polyomavirus-associated hemorrhagic cystitis following allogenic hemopoietic stem cell transplantation. Bone Marrow Transplant. 2000;26(11):1229–30.

    Article  PubMed  CAS  Google Scholar 

  93. Miller J, Burfield GD, Moretti KL. Oral conjugated estrogen therapy for treatment of hemorrhagic cystitis. J Urol. 1994;151(5):1348–50.

    PubMed  CAS  Google Scholar 

  94. Demesmay K, Tissot E, Bulabois CE, et al. Factor XIII replacement in stem-cell transplant recipients with severe hemorrhagic cystitis: a report of four cases. Transplantation. 2002;74(8):1190–2.

    Article  PubMed  CAS  Google Scholar 

  95. Connolly SS, D’Arcy FT, Corcoran MO. Recombinant activated factor VII to control life-threatening hemorrhagic radiation cystitis. Ir J Med Sci. 2010;179:431–3.

    Article  PubMed  CAS  Google Scholar 

  96. Vela-Ojeda J, Tripp-Villanueva F, Sanchez-Cortes E, et al. Intravesical rhGM-CSF for the treatment of late onset hemorrhagic cystitis after bone marrow transplant. Bone Marrow Transplant. 1999;24(12):1307–10.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Virginia Mason Medical Center, Seattle, WA, USA

    Dan J. Lewinshtein

  2. Tan Tock Seng Hospital, Singapore, Singapore

    Kian Tai Chong

  3. Virginia Mason Cancer Institute, 1100, 9th Avenue, Seattle, WA, 98111, USA

    John M. Corman

Authors
  1. Dan J. Lewinshtein
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kian Tai Chong
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. John M. Corman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to John M. Corman .

Editor information

Editors and Affiliations

  1. School of Medicine, Harborview Medical Center, University of Washington, 1959 NE Pacific Street Box 356510, Seattle, 98195, Washington, USA

    Hunter Wessells

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Lewinshtein, D.J., Chong, K.T., Corman, J.M. (2013). Hemorrhagic Cystitis. In: Wessells, H. (eds) Urological Emergencies. Current Clinical Urology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-423-4_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-62703-423-4_14

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-62703-422-7

  • Online ISBN: 978-1-62703-423-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation